ddPCR for the Determination of MSI Status in Patients with Cancer

BIO-RAD
2/4/21, 7:00 PM
Europe/Berlin CET+2

Description

Microsatellite instability (MSI) status is routinely assessed in patients with colorectal and endometrial cancers as it contributes to Lynch syndrome initial screening, tumour prognosis, and selecting patients for immunotherapy. Currently, standard reference methods recommended for MSI/dMMR (deficient MisMatch Repair) testing consist of immunohistochemistry and pentaplex PCR-based assays, however, novel molecular-based techniques are emerging. During this webinar, Dr Alexandre Harlé will present the results of his performance evaluation of the Bio-Rad ddPCR assay.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

ddPCR for the Determination of MSI Status in Patients with Cancer

Inglês

 

Speakers

Alexandre Harlé

 

Link to the Event

Banner to the Event

ddPCR for the Determination of MSI Status in Patients with Cancer